{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T02:40:03Z","timestamp":1738723203040,"version":"3.37.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.euroneuro.2008.10.004","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T09:28:09Z","timestamp":1228123689000},"page":"116-124","source":"Crossref","is-referenced-by-count":10,"title":["The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene"],"prefix":"10.1016","volume":"19","author":[{"given":"Thelma","family":"Schilt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten W.J.","family":"Koeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maartje M.L.","family":"de Win","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janneke R.","family":"Zinkstok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se A.","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Schmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim van","family":"den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2008.10.004_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1076\/clin.17.4.446.27939","article-title":"Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users","volume":"17","author":"Back-Madruga","year":"2003","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib2","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1111\/j.1460-9568.2004.03438.x","article-title":"Prefrontal cortical involvement in verbal encoding strategies","volume":"19","author":"Bor","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0091-3057(93)90520-4","article-title":"Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity","volume":"45","author":"Brodkin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-004-1788-8","article-title":"Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function","volume":"173","author":"Colado","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s002130051035","article-title":"Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence","volume":"145","author":"Dafters","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mpr.6","article-title":"The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance","volume":"14","author":"de Win","year":"2005","journal-title":"Int. J. Methods Psychiatr. Res."},{"year":"2003","series-title":"Jaarbericht 2003. Utrecht: DIMS\/Trimbos-instituut","author":"Drugs Informatie en Monitoring Systeem","key":"10.1016\/j.euroneuro.2008.10.004_bib8"},{"year":"2004","series-title":"Jaarbericht 2004. Utrecht: DIMS\/Trimbos-instituut","author":"Drugs Informatie en Monitoring Systeem","key":"10.1016\/j.euroneuro.2008.10.004_bib9"},{"year":"1986","series-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss","key":"10.1016\/j.euroneuro.2008.10.004_bib57"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/026988110101500406","article-title":"Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug","volume":"15","author":"Fox","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1360-0443.2006.01314.x","article-title":"Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?","volume":"101","author":"Gouzoulis-Mayfrank","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0278-5846(03)00114-3","article-title":"Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users","volume":"27","author":"Gouzoulis-Mayfrank","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.drugalcdep.2004.12.002","article-title":"Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use","volume":"78","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-003-1725-2","article-title":"Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (\u201cbinge\u201d ingestion) low dose of MDMA","volume":"173","author":"Green","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","article-title":"Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions","volume":"66","author":"Gudelsky","year":"1996","journal-title":"J Neurochem."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/dmd.104.001180","article-title":"The mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine (MDMA)","volume":"32","author":"Heydari","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/jpet.104.069260","article-title":"Thioether metabolites of MDA and MDMA inhibit hSERT function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells","volume":"311","author":"Jones","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0306-4522(02)00368-8","article-title":"Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum","volume":"114","author":"Kanthasamy","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0306-4522(02)00556-0","article-title":"Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function","volume":"116","author":"Matsumoto","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib22","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.0931309100","article-title":"Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine","volume":"100","author":"Mattay","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00213-004-1791-0","article-title":"Chronic MDMA (ecstasy) use, cognition and mood","volume":"173","author":"McCardle","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","article-title":"5-HT system and cognition","volume":"23","author":"Meneses","year":"1999","journal-title":"Neuroscience and Biobehavioral Reviews"},{"year":"2005","series-title":"Antenne 2004 Trends in alcohol, tabak en drugs bij jonge Amsterdammers. Antenne","author":"Nabben","key":"10.1016\/j.euroneuro.2008.10.004_bib26"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(25)20405-0","article-title":"Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors","volume":"259","author":"Nash","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0010-9452(78)80049-5","article-title":"Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test","volume":"14","author":"Nelson","year":"1978","journal-title":"Cortex"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0006-3223(99)00098-0","article-title":"Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles","volume":"46","author":"Palmatier","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hup.351","article-title":"Human psychopharmacology of Ecstasy (MDMA): a review of 15\u00a0years of empirical research","volume":"16","author":"Parrott","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib31","first-page":"36","article-title":"Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging","volume":"41","author":"Pirker","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269881106061200","article-title":"Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction","volume":"20","author":"Quednow","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib33","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0006-2952(02)01028-6","article-title":"Reduced (+\/\u2212)-3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro","volume":"63","author":"Ramamoorthy","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0006-3223(01)01177-5","article-title":"Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report","volume":"50","author":"Reneman","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0269881106061515","article-title":"Neuroimaging findings with MDMA\/ecstasy: technical aspects, conceptual issues and future prospects","volume":"20","author":"Reneman","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0269881106063266","article-title":"Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users","volume":"20","author":"Reneman","year":"2006","journal-title":"J. Psychopharmacol."},{"year":"1964","series-title":"L'examen clinique en psychologie","author":"Rey","key":"10.1016\/j.euroneuro.2008.10.004_bib37"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000026664","article-title":"(+\/\u2212)3,4-Methylenedioxymethamphetamine (\u2018Ecstasy\u2019)-induced serotonin neurotoxicity: studies in animals","volume":"42","author":"Ricaurte","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.162.3.609","article-title":"Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users","volume":"162","author":"Roiser","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-006-0495-z","article-title":"The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls","volume":"188","author":"Roiser","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1570-0232(02)00692-X","article-title":"Genotyping single-nucleotide polymorphisms by matrix-assisted laser-desorption\/ionization time-of-flight mass spectrometry","volume":"782","author":"Sauer","year":"2002","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/brain\/124.1.219","article-title":"Prefrontal regions supporting spontaneous and directed application of verbal learning strategies: evidence from PET","volume":"124","author":"Savage","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archpsyc.64.6.728","article-title":"Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study","volume":"64","author":"Schilt","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib44","first-page":"15","article-title":"[The Dutch Reading Test for Adults: a measure of premorbid intelligence level]","volume":"22","author":"Schmand","year":"1991","journal-title":"Tijdschr. Gerontol. Geriatr."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib45","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1046\/j.1471-4159.1999.0722516.x","article-title":"Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum","volume":"72","author":"Shankaran","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3565(25)09490-X","article-title":"The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits","volume":"273","author":"Sprague","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib47","first-page":"427","article-title":"An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine","volume":"19","author":"Sprague","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2003.09.001","article-title":"The external validity of results derived from ecstasy users recruited using purposive sampling strategies","volume":"73","author":"Topp","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0006-2952(94)90386-7","article-title":"The demethylenation of methylenedioxymethamphetamine (\u201cecstasy\u201c) by debrisoquine hydroxylase (CYP2D6)","volume":"47","author":"Tucker","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biopsych.2005.10.024","article-title":"Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond","volume":"60","author":"Tunbridge","year":"2006","journal-title":"Biol. Psychiatry"},{"year":"1997","series-title":"Ecstasy in het uitgaanscircuit (Ecstasy and the Dutch rave scene: A socio-epidemiologic study on the nature and extent of, and the risks involved in using ecstasy and other party drugs at dance events). 1997","author":"Van de Wijngaart","key":"10.1016\/j.euroneuro.2008.10.004_bib51"},{"key":"10.1016\/j.euroneuro.2008.10.004_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/S1355617705050344","article-title":"Rey's verbal learning test: normative data for 1855 healthy participants aged 24\u201381\u00a0years and the influence of age, sex, education, and mode of presentation","volume":"11","author":"Van der Elst","year":"2005","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib53","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.addbeh.2006.11.008","article-title":"How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context","volume":"32","author":"Vervaeke","year":"2006","journal-title":"Addict Behav."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","article-title":"The effects of methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) on monoaminergic neurotransmission in the central nervous system","volume":"49","author":"White","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2008.10.004_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2006.06.034","article-title":"The COMT val158met polymorphism and brain morphometry in healthy young adults","volume":"405","author":"Zinkstok","year":"2006","journal-title":"Neurosci. Lett."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X08002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X08002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T01:39:37Z","timestamp":1738719577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X08002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0924977X08002733"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2008.10.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}